Introduction {#sec0005}
============

Preterm premature rupture of fetal membranes (pPROM) affects 2--4 % of pregnancies accounting for 25 % of preterm birth \[[@bib0005]\]. pPROM near the limit of fetal viability is an uncommon complication of pregnancy, affecting approximately 4 in 1000 gravidas \[[@bib0010]\]. Maternal, fetal, and neonatal complications resulting from this condition are significant including chorioamnionitis, fetal loss, pulmonary hypoplasia and complications of extreme prematurity among surviving infants \[[@bib0010]\].

When delivery is assumed near the limit of viability, families and health care teams face complex and ethically challenging decisions \[[@bib0015]\]. The past studies on the prognosis of pPROM near the limit of survival showed substantially varying prognosis with survival rate raging from 26 to 57 % \[[@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080], [@bib0085]\]. This may be partly due to the fact that treatment of prematurely born babies vary from one country to another, or sometimes within a single country. Though protocols for resuscitation of prematurely born babies theoretically play an important role in determining the prognosis of babies, in the past studies, often they were not specified or even if they were, thresholds for resuscitation were 24 weeks of gestation or later. Thus, in most cases babies born in 22 weeks of gestation are treated with palliative care so as most of those born in 23 weeks.

In our facility in Japan, we actively treat every newborn from 22 weeks of gestation once they react to initial resuscitation. Thus, this study makes the first report of pPROM near the limit of viability in which resuscitation efforts are made uniformly once babies reach 22 weeks of gestation.

The aim of this study was to assess the natural history and short- and long-term prognoses in pregnancies complicated by pPROM between 20 and 23 6/7 weeks of gestation.

Patients and methods {#sec0010}
====================

This is a single-center retrospective cohort study at Tokyo Metropolitan Ohtsuka Hospital, a tertiary referral center in Tokyo, Japan. Inclusion criteria were cases of diagnoses as pPROM at a gestational age of 20--23 6/7 weeks and delivered in our hospital from April 1, 2007, to December 31, 2017. Patients who chose to terminate pregnancy by means of immediate induction of labor and pregnancies complicated by major fetal anomalies were excluded ([Fig. 1](#fig0005){ref-type="fig"}). Because it is illegal in Japan to terminate pregnancy once gestational age reaches 22 weeks, the choice of termination of pregnancy is limited to those with gestational age prior to 22 weeks of gestation.Fig. 1Summary of outcomes of pPROM cases between 20 and 23 6/7 weeks of gestation.Fig. 1

Patient data was obtained from clinical records regarding demographic characteristics, medical and obstetric history, complications and outcomes of the mothers and their neonates. Ethical approval was obtained from the Tokyo Metropolitan Ohtsuka Hospital ethics committee. Informed written consent was waived because this study solely used the data obtained from clinical practice.

Neurodevelopmental assessments of the surviving neonates were conducted in the neonatal follow-up clinic of the hospital in 36 months corrected age using the Kyoto Scale of Psychological Development (KSPD) test. The latest version of the KSPD was standardized in 2001 for children born in Japan, and the mean and 1 SD of the developmental quotient (DQ) were 100.6 and 13.4, respectively \[[@bib0090],[@bib0095]\]. A DQ score of KSPD \< 70, equivalent to a Bayley III cognitive score \<85, \[[@bib0100]\], was interpreted as significantly delayed development according to the protocol by the Japan Neonatal Follow-up Study Group \[[@bib0105]\].

The diagnosis of pPROM was based on visible amniotic fluid with a sterile speculum examination and confirmation by Actim® PROM (Medix Biochemica) that was based on the detection of IGFBP-1 measurement, or ROM-check Membrane Immunoassay (Adeza Biochemical) that was based on the detection of fetal fibronectin depending on the availability.

The management protocol for pPROM included bed rest, daily monitoring of vital signs, uterine contraction and nonstress testing, weekly assessment of biophysical profile, treatment with antibiotics mostly with ampicillin 1 g every 6 or 8 h and oral azithromycin 1 g. The choice of antibiotic agent or duration of administration varied due to the medical conditions of the patient, culture results and attending doctor's discretion. Tocolysis with intravascular ritodrine hydrochloride or magnesium sulfate was conducted in the existence of uterine contraction. Antenatal corticosteroids (two doses of intramuscular 12 mg betamethasone 24 h apart) were administrated when delivery is anticipated within a week. Tocolysis was terminated when a patient was in active labor or developed clinical chorioamnionitis (as diagnosed by fever without another clear source and one or more of the following; tenderness in uterus, white cell count \>15,000/mm \[[@bib0015]\], purulent vaginal discharge). Resuscitation is attempted to every newborn delivered in and after 22 weeks of gestation. Considering the low survival rate of newborn delivered in 22-0/7 to 22-6/7 weeks of gestation, we did not conduct cesarean section for fetal indication for fetus with this gestational age. Otherwise, indication of cesarean section was the same as that for term deliveries.

Severe neonatal morbidity was defined as any of the following neonatal morbidities: 1) bronchopulmonary dysplasia, defined as requirement for oxygen at postmenstrual age of 36 weeks of gestation; 2) severe neurologic injury, defined as grade 3 or 4 intraventricular hemorrhage or periventricular leukomalacia, diagnosed by cranial ultrasonography; and 3) severe retinopathy of prematurity, defined as stage 3 or higher or requiring treatment. Other individual neonatal outcomes included necrotizing enterocolitis stage 2 or greater, seizures, sepsis, contractures, and days to initial discharge from hospitalization.

Severe oligohydramnios was defined at a maximal vertical pocket less than 1 cm or amniotic fluid index (AFI) less than 2 cm. The diagnosis of placental abruption was mainly made on clinical ground with symptoms such as abdominal pain and sign of blood clot attached to the placenta. Gestational age in these pregnancies was based on first-trimester ultrasonogram.

The background maternal characteristics, characteristics of pPROM, and pregnancy complications were compared between pregnancies in which neonates survived to discharge and pregnancies complicated by severe neonatal comorbidities, stillbirth or neonatal death. The chi-squared test and the Fisher's exact test were used to compare categorical variables between the groups, as appropriate. Considering the small sample size, a nonparametric test (Mann-Whitney U-test) was used to compare continuous variables between the groups. We used a multivariate logistic regression analysis in order to identify factors that are independently associated with overall neonatal survival and neonatal survival without severe morbidity. Variables included in the multivariate logistic regression analysis were selected based on the previous studies \[[@bib0075],[@bib0080]\] and the results of univariate analysis after being tested for multicollinearity. Statistical significance was defined with 2-sided p values of \<0.05. We used odds ratios (ORs) with 95 % confidence intervals (95 % CIs). All statistical analyses were performed with The Statistical Package for Social Sciences ver. 23.0 (SPSS, Chicago, IL).

Results {#sec0015}
=======

69 neonates were born to women diagnosed with pPROM at a gestational age of 20--23 6/7 weeks during the study period. After excluding 2 cases where couples chose termination of pregnancy and one case with major abnormalities, 66 cases were included as the study subjects. Of the 66 cases, 54 (81.1 %) newborns survived to discharge ([Fig. 1](#fig0005){ref-type="fig"}). Demographic and obstetric characteristics of the study cohort are presented in [Table 1](#tbl0005){ref-type="table"}. Survivors were born at more advanced gestational age (24w6d ±14.2 days versus 23w4d ±8.6 days, p = 0.035) and had marginally longer latency period (14.8 ± 13.6 days versus 7.9 ± 8.2 days, p = 0.068), compared with those who did not survive. Survivors with no severe neonatal morbidities were less likely to be complicated by severe oligohydramnios than survivors with neonatal morbidities or non-survivors (8.3 % versus 46.3 %, p = 0.018) ([Table 2](#tbl0010){ref-type="table"}). Survivors with no severe neonatal morbidities were born at more advanced gestational age (26w5.8d ±15.6 days compared with 24w1.3d ±10.8, P \< 0.001), had longer latency period (25.9 days ±16.3 versus 10.8 days ±10.45, P = 0.002), and had higher birth weight (903.7 g ± 293.7 versus 623.0 g ± 202.0, P \< 0.001), compared with survivors with severe neonatal morbidities or non-survivors. WBC and CRP at the diagnosis of ruptured membrane were higher in survivors with severe neonatal morbidities or non-survivors compared to survivors with no severe neonatal morbidities (11.3 (10^3^ /μL) ±4.1 versus 13.7 (10^3^ /μL) ±5.0, p = 0.026; 0.95 (mg/L) ±1.78 versus 1.96 (mg/L) ±2.07, p = 0.018).Table 1Characteristics and pregnancy outcomes of survivors and nonsurvivors.Table 1**　AllSurvivorsNonsurvivorsP valuen = 66n = 54n = 12Characteristics**Maternal age (year)32.5 ± 6.132.6 ± 5.531.6 ± 8.70.953Age older than 3521 (31.8)16(29.6)5(41.7)0.313Nulliparity37 (56.1)29(53.7 %)8(66.7 %)0.413GA at pPROM (week)22w5.0d±6.0d22w5.4d±5.5d22w3.6d±7.9d0.405GA at pPROM 22 week or greater54 (81.8)46 (85.2)8 (66.7)0.139Cerclage3 (4.5)2 (3.7)1 (8.3)0.416Severe oligohydramnios26 (39.4)21 (38.9)5 (41.7)0.486**Pregnancy outcomes**Duration of latency (days)13.5 ± 13.014.8 ± 13.67.9 ± 8.150.068Greater than 737 (56.1)32 (59.3)5 (41.7)0.267Greater than 1425 (37.9)23 (42.6)2 (16.7)0.086Greater than 287 (10.6)7 (13.0)0 (0)0.227GA at birth (week)24w4.4d±13.8d24w6.1d±14.2d23w4.5d±8.6d**0.035**24 or greater41 (62.1)35 (64.8)6 (50.0)0.26225 or greater22 (33.3)21 (38.9)1 (8.3)**0.039**26 or greater14 (21.2)14 (25.9)0 (0)**0.042**Birth weight667.5g ± 250.4691.1 g ± 259.8595.2g ± 135.30.146WBC (10^3^/μL)13.3 ± 4.913.0 ± 5.014.5 ± 4.20.151CRP (mg/L)1.77 ± 2.041.73 ± 2.131.97 ± 1.640.345Chorioamnionitis53 (80.3)44 (81.5)9 (75.0)0.436Maternal sepsis1 (1.5)1 (1.9)0 (0)0.818Placental abruption3 (4.5)1 (1.9)2 (16.7)0.083Cord prolapse3 (4.5)3 (5.6)0 (0)0.542Cesarean delivery45 (68.2)37 (68.5)8 (66.7)0.575[^1][^2]Table 2Characteristics and pregnancy outcomes of survivors without severe neonatal morbidities and survivors with severe neonatal morbidities or nonsurvivors.Table 2**Survivors with no severe neonatal morbiditiesNeonatal morbidities or nonsurvivorsP valuen = 12n = 54Characteristic**　　　Maternal age (year)32.4 ± 5.332.4 ± 6.30.967Age older than 353 (25.0)18 (33.3)0.425Nulliparity7 (58.3)30 (55.6)0.861GA at pPROM (week)23w0.8d±5.0d22w4.49d±6.1d0.064GA at pPROM 22 week or greater11 (91.7)43 (79.6)0.303Cerclage0 (0)3 (5.6)0.518Severe oligohydramnios1 (8.3)25 (46.3)**0.018Pregnancy outcomes**　　　Duration of latency (days)25.9 ± 16.310.8 ± 10.45**0.002**Greater than 710 (83.3)27 (50.0)**0.035**Greater than 149 (75.0)16 (29.6)**0.005**Greater than 285 (41.7)2 (3.7)**0.002**GA at birth (week)26w5.8d±15.6d24w1.3d±10.8d**\<0.001**24 or greater12 (100)29 (53.7)**0.002**25 or greater10 (83.3)12 (22.2)**\<0.001**26 or greater8 (66.7)6 (11.1)**\<0.001**Birth weight903.7 g ± 293.7623.0g ± 202.0**\<0.001**WBC (10^3^/μL)11.3 ± 4.113.7 ± 5.0**0.026**CRP (mg/L)0.95 ± 1.781.96 ± 2.07**0.018**Chorioamnionitis10 (83.3)43 (79.6)0.564Maternal sepsis0 (0)1 (1.9)0.818Placental abruption0 (0)3 (5.6)0.542Cord prolapse0 (0)3 (5.6)0.542Cesarean delivery9 (75.0)36 (66.7)0.425[^3][^4]

Of the neonates who survived to discharge, 42 (77.8 % of survivors) had severe morbidity, 34 (63.0 %) with bronchopulmonary dysplasia, 6 (11.1 %) with severe neurologic injury, 25 (46.3 %) with severe retinopathy of prematurity ([Table 3](#tbl0015){ref-type="table"}).Table 3Neonatal Morbidity Among Neonates Who Survived to Discharge.Table 3Survivors (n = 54)OutcomenValueBirth weight (g)691.1 ± 259.8Greater than 500 g4481.5Severe morbidity[\*](#tblfn0005){ref-type="table-fn"}4277.8Bronchopulmonary dysplasia3463.0Severe neurologic injury611.1Seizures23.7Necrotizing enterocolitis59.3ROP stage 3 or greater2546.3sepsis35.6contractures23.7Time to discharge (days)　154.5 ± 52.6[^5][^6][^7]

[Table 4](#tbl0020){ref-type="table"} shows survival rates by gestational age at the time of pPROM. The outcome was better for those with more advanced age when pPROM occurred.Table 4Survival Rate by Gestational Age at the Time of Preterm PROM.Table 4　Gestational Age at Time of Preterm PROM(wk)20w0d-20w6d21w0d-21w6d22w0d-22w6d　23w0d-23w6d　Total　Outcomesn = 3%n = 9%n = 23%n = 31%n = 66%Overall survival133.3777.81982.62787.15481.8Survival without severe morbidity00.0111.1313.0825.81218.2Nonsurvival266.7222.2417.4412.91218.2

Multivariate logistic regression analysis was shown in [Table 5](#tbl0025){ref-type="table"}. Advanced gestational age at pPROM and longer latency period were significantly associated with survival with no severe morbidities (per one day increase, adjusted odds ratio (OR) 1.37, 95 % CI 1.03--1.83, p = 0.033 and per one day increase, adjusted OR 1.11, 95 % CI 1.02--1.21, p = 0.015, respectively). Longer latency period was marginally associated with overall survival (per one day increase, OR1.09, 95 %CI 0.99--1.20, p = 0.079). Higher serum CRP at the time of diagnosis of pPROM and severe oligohydramnios were marginally inversely associated with survival with no severe morbidities (OR 0.16, 95 %CI 0.02--1.08, p = 0.060 and OR 0.05, 95 %CI 0.01--1.08, p = 0.056 respectively).Table 5Variables Associated with Neonatal Survival: Multivariate Analysis.Table 5Overall Survival　Neonatal Survival with No Severe Morbidity　Adjusted OR (95 % CI)p valueAdjusted OR (95 % CI)p valueNulliparity0.76 (0.19--3.11)0.7062.98(0.26--34.63)0.382Gestational age at rupture (per 1 day increase)1.08 (0.96-1.22)0.2101.37(1.03--1.83)**0.033**Latency (per 1 day increase)1.09 (0.99--1.20)0.0791.11(1.02--1.21)**0.015**CRP (mg/L) per 1 mg/L increase1.06 (0.75--1.45)0.7500.16(0.02--1.08)0.060Severe oligohydramnios1.39 (0.32--6.12)0.6650.05(0.01--1.08)0.056[^8][^9][^10][^11]

A total of 23 of the 54 survivors were followed at 36 months corrected age. This is because many are referred to facilities closer to their residence.

Of those followed at 36 months, 8 (34.8 %) had developmental delay.

Discussion {#sec0020}
==========

In this study, we examined prognosis of pPROM between 20 and 23 6/7 weeks of gestation. Considering the low incidence of pPROM of this gestational age, our study presents important findings for prognosis of pPROM near the limit of viability which were managed in a single referral center using a standard contemporary protocol. This is also one of few studies that provided long-term prognosis of such cases.

The past studies on the prognosis of pPROM near the limit of survival showed substantially varying, but generally poor, prognosis with survival rate raging from 26 to 57 % \[[@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080], [@bib0085]\], morbidity ratio from 37 to 83 %. This may be partly due to the fact that the past studies included different gestational ages where pPROM occurred; some included 14--23 weeks \[[@bib0030], [@bib0035], [@bib0040], [@bib0045]\], while others included up to 28 weeks of gestational age \[[@bib0055]\]. Also, protocols for resuscitation of prematurely born babies vary though they theoretically play an important role on determining the prognosis of babies. In most studies neonates were resuscitated from 24 to 26 weeks of gestation \[[@bib0025],[@bib0040],[@bib0045]\] or others did not specify the threshold for resuscitation. In the study of Kibel et al. \[[@bib0075]\], each couple determined the threshold of gestational age at birth (23, 24, or 25 weeks) beyond which they would want an active resuscitation of the newborn and as a result 26 out of 104 newborns were treated with palliative care.

Our study makes the first report of prognosis of pPROM in which resuscitation efforts are made uniformly once babies reach 22 weeks of gestation. As a result, the survival rate of pPROM between 20 and 24 weeks of gestation in our study was above 80 %, which was much higher than the previous studies. In the previous report from Kibel et al. \[[@bib0075]\] of pPROM in the same periods of gestational weeks as ours, survival rate to discharge was 49.0 %.

On the other hand, of those who survived to discharge, 78 % had severe morbidities, which was higher than 47 % in the report from Kibel et al. \[[@bib0075]\] One of the reasons behind contrasting results of neonatal survival and the rate of morbidity may be derived from our protocols on neonatal resuscitation. This analysis is coherent with the fact that the mean gestational age and weight at birth in those who survived in Kibel's study were 26.1 weeks and 922 g, respectively, while in our study they were 24w6d and 691 g. Because the morbidity rate is largely dependent upon gestational age and weight at birth, the rise in comorbidity is explained by immaturity of newborns in our study. In other words, we might have saved the lives of less mature newborns who would have been treated with palliative care in Kibel's study.

Variables that are independently associated with better prognosis were similar to the previous studies. Gestational age at rupture of membrane and longer latency periods were associated with survival with no severe morbidities. One of the important findings in our study was that higher serum CRP at the time of diagnosis of ruptured membrane and severe oligohydramnios were inversely associated with survival with no severe morbidities. Identification of risk factors for adverse perinatal outcome will allow healthcare professionals to individualize counseling for pregnancies complicated by pPROM near the limit of viability. Higher CRP and oligohydramnios had moderate association with shorter latency, which might have resulted in increased morbidities (correlation coefficient between shorter latency and CRP was 0.405 and that for oligohydramnios was 0.284). Oligohydramnios can prohibit lung maturation and thus can affect prognosis.

We acknowledge several limitations of our study. First, a relatively small sample size due to rarity of pPROM. Second, the follow-up rate at 36 months was not very high. Of the 54 survivors, the follow-up data was obtained from only 23. Because our facility is a tertiary referral center in the urban Tokyo, babies are often referred back to their nearby hospitals once they become stable.

Yet, our findings are important because this is the first report on the prognosis of pPROM near the limit of viability from a facility in Japan where neonates were resuscitated from 22 weeks of gestation.

In summary, the overall neonatal survival rate was over 80 % for pPROM between 20 and 23 6/7 weeks of gestation, and 78 % of survived newborns were with severe morbidities at the time of discharge.
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[^1]: Data are mean ± standard deviation or n (%), unless otherwise specified.

[^2]: Bold indicates significant P values.

[^3]: Data are mean ± standard deviation or n (%) unless otherwise specified.

[^4]: Bold indicates significant P values.

[^5]: ROP, retinopathy of prematurity.

[^6]: Data are mean ± standard deviation, % \[95 % confidence interval\], or median (interquartile range) unless otherwise specified.

[^7]: Refers to any of the following conditions: bronchopulmonary dysplasia, severe neurologic injury(intraventricular hemorrhage grade 3 or 4 or periventricular leukomalacia), or retinopathy of prematurity stage 3 or greater.

[^8]: Data are adjusted odds ratio (95 % confidence interval).

[^9]: Values reflect the results of multivariable logistic regression analysis.

[^10]: All the covariates that were used as adjustors are listed in the table.

[^11]: Bold indicates significant associations.
